ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Lung Cancer
Rectal Cancer

Colon Cancer trials near Salt Lake City, UT, USA:

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

Salt Lake City, Utah, United States and 15 other locations

The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer...

Enrolling
Metastatic Breast Cancer (HR+/ HER2-)
Triple Negative Breast Cancer
Drug: Cetuximab
Drug: PF-08032562

Phase 1

Pfizer
Pfizer

West Valley City, Utah, United States of America and 2 other locations

This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...

Active, not recruiting
Any Solid Tumor
Colon Cancer
Drug: LOXO-292

Phase 1, Phase 2

Lilly
Lilly

Salt Lake City, Utah, United States and 85 other locations

This study will test the safety of a drug called PF-08046052/SGN-EGFRd2 in participants with advanced solid tumors. It will also study the s...

Active, not recruiting
Colorectal Neoplasms
Squamous Cell Carcinoma of the Head and Neck
Drug: PF-08046052

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Salt Lake City, Utah, United States and 23 other locations

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor...

Enrolling
Stage III Colon Cancer
Drug: mFOLFOX6 3-6 month
Device: Signatera test

Phase 2, Phase 3

NRG Oncology
NRG Oncology

Salt Lake City, Utah, United States and 1031 other locations

of SNS-101, a novel anti VISTA IgG1 monoclonal antibody as monotherapy or in combination with cemiplimab in patients with advanced solid tumors...

Active, not recruiting
Breast Cancer
Uterine Cancer
Drug: Cemiplimab
Drug: SNS-101 (anti-VISTA)

Phase 1, Phase 2

Sensei Biotherapeutics

West Valley City, Utah, United States of America and 9 other locations

Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants with Advanced or Metastatic Select Solid Tumors...

Enrolling
CRC (Colorectal Cancer)
NSCLC (Advanced Non-small Cell Lung Cancer)
Drug: ALX2004

Phase 1

ALX Oncology

West Valley City, Utah, United States of America and 6 other locations

multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors...

Enrolling
Lung Cancer (Non-Small Cell)
Breast Cancer
Drug: ADC

Phase 1, Phase 2

MBrace Therapeutics

West Valley City, Utah, United States and 5 other locations

Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab ver...

Active, not recruiting
Metastatic Colorectal Cancer
Advanced Colorectal Cancer
Drug: MRTX849
Biological: Cetuximab

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Salt Lake City, Utah, United States and 427 other locations

versus a fluoropyrimidine/bevacizumab alone as assessed by molecular response which is based on changes in circulating tumor (ct)DNA. The...

Active, not recruiting
Colorectal Neoplasms
Drug: Ipilimumab
Drug: Atezolizumab

Phase 2, Phase 3

Seattle Project Corporation

Salt Lake City, Utah, United States and 42 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems